UK biotech Scancell has reported data from a phase 2 trial of its off-the-shelf DNA plasmid vaccine for melanoma that it says backs a swift move to a larger, registrational study. The SCOPE trial of ...

It has been around a year since Beam Therapeutics slashed its headcount and R&D programmes to focus mainly on a sickle cell disease candidate – and the biotech has now revealed the first data with the ...

Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician (CMT). A line of best fit is a form of regression analysis that shows the relationship ...

President Donald Trump’s approval rating dipped to 40%, a low point for his second term, in the latest Reuters/Ipsos poll released Wednesday, as two polls show Americans blame Republicans more than ...

The Rasmussen Reports daily Presidential Tracking Poll for Friday shows that 51% of Likely U.S. Voters approve of President Trump’s job performance. Forty-seven (47%) disapprove. The latest figures ...

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and ...

The Rasmussen Reports daily Presidential Tracking Poll for Thursday shows that 49% of Likely U.S. Voters approve of President Trump’s job performance. Fifty (50%) disapprove. The latest figures ...

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud ...